LBT Innovations Ltd. | Income Statement

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
3,920.00
2,324.00
138.00
330.00
5,704.00
Cost of Goods Sold (COGS) incl. D&A
1,855.00
-
2,157.00
2,295.00
2,493.00
Gross Income
2,065.00
-
2,019.00
1,965.00
3,211.00
SG&A Expense
2,848.00
1,667.00
1,083.00
6,880.00
6,488.00
EBIT
971.00
107.00
-
8,845.00
3,277.00
Unusual Expense
-
-
7,519.00
5,869.00
-
Non Operating Income/Expense
-
148.00
144.00
4,989.00
193.00
Interest Expense
-
32.00
27.00
-
-
Pretax Income
971.00
244.00
4,361.00
9,609.00
3,274.00
Income Tax
1,263.00
657.00
543.00
4,619.00
1,616.00
Equity in Affiliates
-
92.00
241.00
143.00
1,027.00
Consolidated Net Income
292.00
321.00
3,577.00
5,133.00
2,685.00
Net Income
292.00
321.00
3,577.00
5,133.00
2,685.00
Net Income After Extraordinaries
292.00
321.00
3,577.00
5,133.00
2,685.00
Net Income Available to Common
292.00
321.00
3,577.00
5,133.00
2,685.00
EPS (Basic)
0.00
0.00
0.03
0.04
0.02
Basic Shares Outstanding
99,647.00
113,507.30
114,988.10
127,763.30
158,209.20
EPS (Diluted)
0.00
0.00
0.03
0.04
0.02
Diluted Shares Outstanding
99,647.00
113,507.30
114,988.10
127,763.30
158,209.20
EBITDA
254.00
657.00
2,327.00
8,086.00
3,224.00
Other Operating Expense
188.00
-
-
-
-
Non-Operating Interest Income
-
43.00
115.00
116.00
196.00

About LBT Innovations

View Profile
Address
44 Waymouth Street
Adelaide South Australia (SA) 5000
Australia
Employees -
Website http://www.lbtinnovations.com
Updated 07/08/2019
LBT Innovations Ltd. is an Australian developer of clinical and diagnostic technology, which has emerged as a groundbreaking designer of advanced automated solutions for the preparation and analysis of microbiology culture specimens, with significant benefits for busy clinical laboratories. The firm operates its business through research and development segments. The company was founded by Lusia Halina Guthrie, Douglas Peter LeMessurier and Paul Andrew Mariani in 2004 and is headquartered in Adelaide, Australia.